Thanks bigb888. The following comments have caught my attention:
It is unheard of to have positive data from three rare paediatric disorders for one compound
Our focus is on later stage companies that are only one or two milestones away from being an attractive acquisition target,”
Neuren Media and Analyst Coverage, page-1276
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.14 |
Change
-0.250(1.29%) |
Mkt cap ! $2.443B | |||
| Open | High | Low | Value | Volume |
| $19.55 | $19.65 | $18.88 | $5.553M | 290.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 146 | $19.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.14 | 18 | 5 |
View Market Depth
| Last trade - 14.53pm 31/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |